Presentation TCT 2013 What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)? Presenter: Nils Johnson October 31, 2013
Presentation TCT 2013 What Is Ischemia? Is There a Gold Standard, and How Should New Modalities Be Evaluated? Presenter: Habib Samady October 31, 2013
Presentation TCT 2013 Pro Position: Randomized Trial Results Support Incorporating FFR Into Most PCI Procedures! Presenter: Habib Samady October 31, 2013
Presentation TCT 2013 iFR: Background, Physiologic Rationale for Basal Indices, and Clinical Data Presenter: Justin Davies October 31, 2013
Presentation TCT 2013 Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score) Presenter: Chang-Wook Nam October 31, 2013
Presentation TCT 2013 Cases V and VI: Acute Coronary Syndromes Presenter: Allen Jeremias October 31, 2013
Presentation TCT 2013 Cases III and IV: Left Main and Bifurcation Lesions Presenter: Bon-Kwon Koo October 31, 2013
Presentation TCT 2013 Can Basal Modalities Ever Be as Good as Hyperemic Indices? Presenter: Nils Johnson October 31, 2013
Presentation TCT 2013 Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data Presenter: Tim van de Hoef October 31, 2013
Presentation TCT 2013 Practical Aspects of FFR: Lesion Assessment and Tips and Tricks to Avoid Mistakes Presenter: Michael Lim October 30, 2013
News Conference News TCT 2013 Novel Ischemia Measurement Strategies Show Potential vs. FFR October 30, 2013
Presentation TCT 2013 How I Integrate FFR and IVUS in the Cath Lab and Why Presenter: Soo-Jin Kang October 30, 2013
Presentation TCT 2013 HeartFlowNXT: A Prospective, Registry Evaluation of Noninvasive FFRCT vs. Invasive FFR Presenter: Bjarne N?rgaard October 30, 2013
Presentation TCT 2013 FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease Presenter: Pim Tonino October 30, 2013